Yoichi Matsuo
- Oncology top 2%
- Pancreatic and Hepatic Oncology Research 27
- Colorectal Cancer Surgical Treatments 15
- Chemokine receptors and signaling 11
- Cancer Research top 5%
- Immunology and Allergy top 5%
- Immunology top 5%
- Molecular Biology top 5%
- Angiogenesis and VEGF in Cancer 12
- PI3K/AKT/mTOR signaling in cancer 9
-
- Gastric Cancer Management and Outcomes 13
-
- Gastrointestinal Tumor Research and Treatment 11
-
- Neuroendocrine Tumor Research Advances 11
- Co-authors
- Hiroki TakahashiHiromitsu TakeyamaHirozumi SawaiHitoshi FunahashiNobuo OchiAkira YasudaYuji OkadaSushovan Guha
- Partner nations
- JapanUnited StatesGreece
In The Last Decade
Yoichi Matsuo
137 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 113
- Oncology 1.3k
- Cancer Research 563
- Immunology and Allergy 190
- Immunology 552
- Molecular Biology 1.3k
Countries citing papers authored by Yoichi Matsuo
This map shows the geographic impact of Yoichi Matsuo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoichi Matsuo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoichi Matsuo more than expected).
Fields of papers citing papers by Yoichi Matsuo
This network shows the impact of papers produced by Yoichi Matsuo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoichi Matsuo. The network helps show where Yoichi Matsuo may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yoichi Matsuo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 6 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 2 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 0 | |
| 10 | 2022 | 4 | |
| 11 | 2021 | 9 | |
| 12 | 2021 | 2 | |
| 13 | [A Case of Gallbladder Cancer with Para-Aortic Lymph Node Metastasis Successfully Treated by Gemcitabine plus Cisplatin Combination Chemotherapy and Conversion Surgery]. | 2020 | 2 |
| 14 | 2011 | 21 | |
| 15 | 2009 | 68 | |
| 16 | IGF-1 and PTEN regulate the proliferation and invasiveness of colon cancer cells through opposite effects on PI3K/Akt signalling | 2009 | 4 |
| 17 | 2008 | 144 | |
| 18 | Glial cell line-derived neurotrophic factor enhances the invasive ability of pancreatic cancer cells by regulating urokinase-type plasminogen activator and matrix metalloproteinase | 2008 | 2 |
| 19 | Basic research TGF-β regulates invasive behavior of human pancreatic cancer cells by controlling Smad expression | 2007 | 3 |
| 20 | 2007 | 4 |
About Yoichi Matsuo
Yoichi Matsuo is a scholar working on Oncology, Gastroenterology and Immunology and Allergy, having authored 153 papers that have together received 3.0k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (27 papers), Colorectal Cancer Surgical Treatments (15 papers), Gastric Cancer Management and Outcomes (13 papers), Angiogenesis and VEGF in Cancer (12 papers), Gastrointestinal Tumor Research and Treatment (11 papers), Neuroendocrine Tumor Research Advances (11 papers), Chemokine receptors and signaling (11 papers) and PI3K/AKT/mTOR signaling in cancer (9 papers). The work is most often cited by research in Oncology (1.3k citations), Cancer Research (563 citations) and Immunology and Allergy (190 citations). Yoichi Matsuo has collaborated with scholars based in Japan, United States and Greece. Frequent co-authors include Hiroki Takahashi, Hiromitsu Takeyama, Hirozumi Sawai, Hitoshi Funahashi, Nobuo Ochi, Akira Yasuda, Yuji Okada, Sushovan Guha, Tadao Manabe and Zhimin Tong.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.